Matthew Calistri | Vice President, Corporate Strategy and Investor Relations |
Tony Coles | Chairperson and Chief Executive Officer |
Raymond Sanchez | Chief Medical Officer |
John Renger | Chief Scientific Officer |
Mark Bodenrader | Interim Chief Financial Officer |
Paul Matteis | Stifel |
Joseph Thome | TD Cowen |
Michael Yee | Jefferies |
Jessica Fye | JP Morgan |
Graig Suvannavejh | Mizuho Securities |
Omari Baruti | Goldman Sachs |
Douglas Tsao | H.C. Wainwright |
Elaine Kim | Cantor Fitzgerald |
Good morning and welcome to Cerevel Therapeutics First Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Please note that this call may be recorded.
I will now hand the call over to Matt Calistri, Vice President of Investor Relations.
Thank you.